ARCHIVES

FDA Consider Regulation of CME Programs Paid for By Drug Companies; Goal To Limit Promotion

This article is from The Cancer Letter archive.

Vol. 18 No. 01 | January 3, 1992

Download PDF Visit The Full Archive

Related Articles

In Brief: Moffitt Gets $100M From Fla. For Construction; Two Head And Neck Surgical Societies Merge

July 3, 1998

Centers Structures, Governance, Funding, Review considered By NCI, NCAB, Center Directors

September 30, 1977

FDA carries Action On Two Cancer Drugs Over To 1996

January 5, 1996

NCI contract Award

August 1, 1997

Tamoxifen: No Mortality Benefit For Most “High Risk” Women

September 29, 2006

In Brief: Public Favors stronger Laws Restricting Teen Smoking; Anderson Expands Pediatric Studies

April 26, 1991